A Randomized, Double-Blind, Placebo-Controlled, Two-way Crossover Drug-drug Interaction Study to Assess the Effect of Laquinimod 0.6 mg on the Pharmacokinetics and Pharmacodynamics of Ethinylestradiol and Levonorgestrel in Healthy Young Women
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2015
At a glance
- Drugs Laquinimod (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Multiple sclerosis; Pregnancy
- Focus Pharmacokinetics
- Sponsors Teva Pharmaceutical Industries
- 26 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 20 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 19 Mar 2014 New trial record